Opus Genetics, Inc. (IRD) Insider Trading

Name: Opus Genetics, Inc. (IRD) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 2, 2026): Foundation Fighting Blindness Retinal Degeneration Fund (Director): Sale of 556,000 shares, $2.76M.

Get alerted when insiders trade IRD

Email address

Loading company data...

Loading company details...